Clinical Trial Update: Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection. [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of MPC-4326 for HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MPC-4326

Snippet

Sponsor: Myrexis Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED